SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-012098
Filing Date
2024-04-01
Accepted
2024-04-01 06:06:13
Documents
63
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 890139
2 ex5-1.htm EX-5.1 4375
3 ex31-1.htm EX-31.1 18991
4 ex31-2.htm EX-31.2 19377
5 ex32-1.htm EX-32.1 7274
6 ex5-1_001.jpg GRAPHIC 263479
7 ex5-1_002.jpg GRAPHIC 430513
8 ex5-1_003.jpg GRAPHIC 329286
9 ex5-1_004.jpg GRAPHIC 403027
10 ex5-1_005.jpg GRAPHIC 330252
11 ex5-1_006.jpg GRAPHIC 354124
12 ex5-1_007.jpg GRAPHIC 271130
  Complete submission text file 0001493152-24-012098.txt   7416383

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE gcan-20231231.xsd EX-101.SCH 34982
14 XBRL CALCULATION FILE gcan-20231231_cal.xml EX-101.CAL 33252
15 XBRL DEFINITION FILE gcan-20231231_def.xml EX-101.DEF 173760
16 XBRL LABEL FILE gcan-20231231_lab.xml EX-101.LAB 247780
17 XBRL PRESENTATION FILE gcan-20231231_pre.xml EX-101.PRE 217990
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 476537
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

IRS No.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56027 | Film No.: 24805396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)